State Key Laboratory of Characteristic Chinese Medicine Resources in Southwest China, Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, People's Republic of China.
School of Pharmaceutical Sciences, Shenzhen University Health Science Center, Shenzhen 518060, People's Republic of China.
Bioorg Chem. 2021 Feb;107:104523. doi: 10.1016/j.bioorg.2020.104523. Epub 2020 Nov 30.
Chuanxiongdiolides R4-R6 (1-3), three novel phthalide dimers featuring two classes of unreported monomeric units (ligustilide/senkyunolide A and ligustilide/neocnidilide) with an unprecedented linkage style (3a,7'/7a,7'a), were isolated from the aerial parts of Ligusticum chuanxiong, together with three pairs of enantiomeric phthalide dimers [(-)/(+)-4a/4b, 5a/5b, and 6a/6b]. The bioassays revealed that compounds 1, 3, 4, 5, and 6 showed significant vasodilation effects, and the mechanism may be attributed to Ca1.2 activation blockade. Based on the established compounds library, the structure activity relationship of the phthalides was proposed. Our findings afford possible leads for developing new vasodilator against cardiovascular and cerebrovascular diseases such as hypertension and ischemic stroke.
川芎内酯 R4-R6(1-3),三种新型的邻苯二甲酸二聚体,具有两类未报道的单体单元(藁本内酯/川芎嗪 A 和藁本内酯/新蛇床内酯),具有前所未有的连接方式(3a,7'/7a,7'a),从川芎的地上部分分离出来,还分离到了三对对映体邻苯二甲酸二聚体[(-)/(+)-4a/4b、5a/5b 和 6a/6b]。生物测定显示,化合物 1、3、4、5 和 6 表现出显著的血管舒张作用,其机制可能归因于 Ca1.2 激活阻断。基于建立的化合物库,提出了邻苯二甲酸酯的构效关系。我们的发现为开发治疗高血压和缺血性中风等心血管和脑血管疾病的新型血管扩张剂提供了可能的先导化合物。